United Therapeutics Corp

Silver Spring, MD
2016 RankN/A
Revenue (US$ Millions)$1,599
Revenue Growth (%)9.10%
Total Equity (US$ Millions)$1,862
Total Assets (US$ Millions)$2,326
Sales Turnover0.69
Revenues Past (US$ Millions)$1,466
Return On Equity (%)44.60%
PE Ratio9.61
Net Income (US$ Millions)$714
Market Cap (US$ Millions)$6,163
Long Term Debt (US$ Millions)N/A
Inventory Turnover0.8
Inventories (US$ Millions)$100
Earnings Per Share (US$)$15
Debt To Equity Ratio (%)N/A
Current Liabilities (US$ Millions)$333
Current Assets (US$ Millions)$1,425
Cost Of Goods Sold (US$ Millions)$73
Common Shares Out (Millions)42.97